MX362129B - Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana. - Google Patents

Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.

Info

Publication number
MX362129B
MX362129B MX2014008513A MX2014008513A MX362129B MX 362129 B MX362129 B MX 362129B MX 2014008513 A MX2014008513 A MX 2014008513A MX 2014008513 A MX2014008513 A MX 2014008513A MX 362129 B MX362129 B MX 362129B
Authority
MX
Mexico
Prior art keywords
bifidobacteria
growth
modulation
combination
human milk
Prior art date
Application number
MX2014008513A
Other languages
English (en)
Inventor
Curtis Frantz David
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45809349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX362129(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX362129B publication Critical patent/MX362129B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

La presente invención se refiere a una formulación líquida o seca de prebióticos para la administración oral a un humano, caracterizad porque comprende a) 0.5-2 mg/ml de 2´-fucosilactosa, 1-4 mg/ml de 3´-sialilactosa y 0.5-2 mg/ml de 6´-sialilactosa, cuando dicho formulación es líquida, o b) al menos 0.4% del peso de 6´-sialilactosa, cuando dicha formulación es un polvo seco.
MX2014008513A 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana. MX362129B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161441451P 2011-02-10 2011-02-10
PCT/IB2012/050511 WO2012107865A2 (en) 2011-02-10 2012-02-03 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Publications (1)

Publication Number Publication Date
MX362129B true MX362129B (es) 2019-01-07

Family

ID=45809349

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014008513A MX362129B (es) 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.
MX2013009087A MX345413B (es) 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2013009087A MX345413B (es) 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.

Country Status (18)

Country Link
US (3) US20140371173A1 (es)
EP (2) EP2672844B2 (es)
CN (2) CN103347405A (es)
AU (1) AU2012215042B2 (es)
BR (1) BR112013020108A2 (es)
CA (1) CA2825697A1 (es)
CL (1) CL2013002210A1 (es)
ES (2) ES2692533T3 (es)
IL (1) IL227487A (es)
MX (2) MX362129B (es)
MY (1) MY161034A (es)
PL (1) PL2672844T3 (es)
PT (1) PT2672844E (es)
RU (1) RU2586928C2 (es)
SG (1) SG192095A1 (es)
TW (1) TW201244640A (es)
WO (1) WO2012107865A2 (es)
ZA (1) ZA201306751B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140371173A1 (en) 2011-02-10 2014-12-18 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
JP2015512936A (ja) * 2012-04-13 2015-04-30 トラスティーズ オブ ボストン カレッジ プレバイオティクス組成物およびその使用方法
DK2708145T3 (en) 2012-09-14 2016-07-18 Abbott Lab Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
SG11201608248YA (en) 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
CN107249611A (zh) * 2014-10-24 2017-10-13 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
EP3223826A1 (en) * 2014-11-26 2017-10-04 Abbott Laboratories Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic
WO2016086157A1 (en) * 2014-11-26 2016-06-02 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
MX2017010923A (es) * 2015-03-05 2018-01-16 Nestec Sa Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
ES2950489T3 (es) 2015-10-28 2023-10-10 Glycom As Composición sintética y método para modular los trastornos de la emoción y del ánimo
ES2927009T3 (es) 2015-10-28 2022-10-31 Glycom As Composición sintética y método para modular la función cerebral y la conducta
MY186217A (en) * 2015-12-15 2021-06-30 Nestle Sa Mixture of hmos
SG10202100843TA (en) * 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
WO2018237149A1 (en) * 2017-06-21 2018-12-27 Abbott Laboratories METHODS FOR INCREASING THE GROWTH OF BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT
US20220241354A1 (en) * 2019-06-05 2022-08-04 Morinaga Milk Industry Co., Ltd. Composition
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
TWI265008B (en) 2000-02-17 2006-11-01 Wyeth Corp Nutritional formulation comprising oligofructose and sialyllactose
US20010034477A1 (en) * 2000-02-18 2001-10-25 James Mansfield Multivariate analysis of green to ultraviolet spectra of cell and tissue samples
US6913778B2 (en) 2001-12-21 2005-07-05 Wyeth Infant formula compositions comprising increased amounts of alpha-lactalbumin
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
CA2548140A1 (en) † 2003-12-05 2005-06-23 University Of Massachusetts Oligosaccharide compositions and use thereof in the treatment of infection
WO2007051475A1 (en) 2005-11-04 2007-05-10 Arla Foods Amba A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
NL2001377C2 (nl) 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
RU2012107695A (ru) * 2009-07-31 2013-09-10 Нестек С.А. Питательная композиция для вскармливаемых грудью детей или домашних животных с пробиотиками и подобранными питательными веществами
NL2004200C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
EP2563165A1 (en) * 2010-04-27 2013-03-06 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
CA2822660C (en) * 2010-12-31 2021-09-07 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides
US20140371173A1 (en) 2011-02-10 2014-12-18 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Also Published As

Publication number Publication date
EP2672844B1 (en) 2014-11-19
ZA201306751B (en) 2015-05-27
CN104126749A (zh) 2014-11-05
ES2692533T3 (es) 2018-12-04
EP2672844A2 (en) 2013-12-18
CA2825697A1 (en) 2012-08-16
CL2013002210A1 (es) 2014-01-10
RU2013141449A (ru) 2015-03-20
EP2792252A2 (en) 2014-10-22
IL227487A0 (en) 2013-09-30
EP2792252A3 (en) 2015-03-25
TW201244640A (en) 2012-11-16
SG192095A1 (en) 2013-08-30
EP2672844B2 (en) 2022-10-05
US20120208782A1 (en) 2012-08-16
US20150141367A1 (en) 2015-05-21
MX345413B (es) 2017-01-27
IL227487A (en) 2015-10-29
ES2527200T3 (es) 2015-01-21
CN103347405A (zh) 2013-10-09
ES2527200T5 (es) 2022-12-29
PT2672844E (pt) 2015-02-04
EP2792252B1 (en) 2018-09-12
BR112013020108A2 (pt) 2017-06-13
US20140371173A1 (en) 2014-12-18
WO2012107865A2 (en) 2012-08-16
PL2672844T3 (pl) 2015-04-30
RU2586928C2 (ru) 2016-06-10
AU2012215042B2 (en) 2016-01-14
MY161034A (en) 2017-04-14
WO2012107865A3 (en) 2012-11-01
MX2013009087A (es) 2013-09-13

Similar Documents

Publication Publication Date Title
MY161034A (en) Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
EP3904502A3 (en) Compositions and methods
NZ613180A (en) Methods of using human milk oligosaccharides for improving airway respiratory health
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
MX362626B (es) Métodos para tratar pacientes pediátricos usando dexmedetomidina..
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
NZ612105A (en) Human milk oligosaccharides for modulating inflammation
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
NZ612386A (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MX368124B (es) Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
NZ701607A (en) Therapeutic use of chardonnay seed products
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2014110353A9 (en) Notch ligand bound biocompatible substrates and their use in bone formation
GB201200858D0 (en) Prebiotic powder composition and uses thereof
WO2011044523A3 (en) Compositions and methods for treating obesity
EA201390417A1 (ru) Антидиабетические твердые фармацевтические композиции
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
PH12014501822A1 (en) Oral formulation comprising lansoprazole and the preparation method thereof
WO2011028797A3 (en) Treatment of glaucoma and other retinopathies with gangliosides
MX2009011214A (es) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.
梁凌智 Preliminary study of smile correlative esthetic factors
TH141699A (th) การควบคุมการเจริญเติบโตของไบฟิโดแบคทีเรียโดยใช้สารรวมของโอลิโกแซคคาไรด์ที่พบในน้ำนมมนุษย์